FDA Approves New Use for Micardis(R) in Cardiovascular Risk Reduction and ... - Reuters PDF Print
ReutersIn patients whose renal function may depend on the activity of the renin-angiotensin-aldosterone system (eg, patients with severe CHF), treatment with

... read more

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.